SymBio Pharmaceuticals Limited — Investor Relations & Filings
Filings indexed
87
across all filing types
Latest filing
2026-06-01
Share Issue/Capital Cha…
Country
JP
Japan
Listing
T
4582
SymBio Pharmaceuticals Limited is a specialty pharmaceutical company focused on the development and commercialization of new drug candidates. The company's business model involves acquiring development and marketing rights for promising pharmaceuticals from other bio-ventures and pharmaceutical firms to address unmet medical needs. Its core therapeutic areas include oncology, hematology, and rare diseases. A key product in its portfolio is bendamustine hydrochloride (Treakisym), an agent used in the treatment of hematologic cancers such as low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. SymBio aims to deliver innovative treatments to patients by advancing its pipeline of specialized drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第三者割当により発行された第58回新株予約権及び第66回新株予約権（行使価額修正条項付）の 月間行使状況に関するお知らせ | 2026-06-01 | Japanese | |
| 超高感度（ピコレベル）イムノクロマトシステム 商業化に向け、安定供給体制を確立 | 2026-05-18 | Japanese | |
| 2026年12月期 第１四半期決算短信〔日本基準〕(連結) | 2026-05-07 | Japanese | |
| 第三者割当により発行された第58回新株予約権及び第66回新株予約権（行使価額修正条項付）の 月間行使状況に関するお知らせ | 2026-05-01 | Japanese | |
| 第三者割当により発行された第66回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ | 2026-04-21 | Japanese | |
| 当社従業員に対して発行する新株予約権（ストックオプション）の発行内容等確定に関するお知らせ | 2026-04-17 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 47912521 | 第三者割当により発行された第58回新株予約権及び第66回新株予約権（行使価額修正条項付）の 月間行使状況に関するお知らせ | 2026-06-01 | Japanese | ||
| 46541081 | 超高感度（ピコレベル）イムノクロマトシステム 商業化に向け、安定供給体制を確立 | 2026-05-18 | Japanese | ||
| 46881343 | 2026年12月期 第１四半期決算短信〔日本基準〕(連結) | 2026-05-07 | Japanese | ||
| 46880510 | 第三者割当により発行された第58回新株予約権及び第66回新株予約権（行使価額修正条項付）の 月間行使状況に関するお知らせ | 2026-05-01 | Japanese | ||
| 46878077 | 第三者割当により発行された第66回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ | 2026-04-21 | Japanese | ||
| 46877490 | 当社従業員に対して発行する新株予約権（ストックオプション）の発行内容等確定に関するお知らせ | 2026-04-17 | Japanese | ||
| 46877486 | 当社取締役に対して発行する新株予約権（ストックオプション）の発行内容等確定に関するお知らせ | 2026-04-17 | Japanese | ||
| 34653888 | 訂正臨時報告書 | 2026-04-17 | Japanese | ||
| 33018657 | 確認書 | 2026-03-24 | Japanese | ||
| 33018652 | 有価証券報告書－第21期(2025/01/01－2025/12/31) | 2026-03-24 | Japanese | ||
|
2025
5 filings
| |||||
| 7859343 | 確認書 | 2025-08-05 | Japanese | ||
| 7859526 | 訂正有価証券届出書（参照方式） | 2025-08-04 | Japanese | ||
| 7859527 | 半期報告書－第21期(2025/01/01－2025/12/31) | 2025-08-04 | Japanese | ||
| 7859673 | 訂正有価証券届出書（参照方式） | 2025-07-31 | Japanese | ||
| 7859944 | 有価証券届出書（参照方式） | 2025-07-22 | Japanese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SymBio Pharmaceuticals Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13616/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13616 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13616 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13616 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13616}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SymBio Pharmaceuticals Limited (id: 13616)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.